Form 483

Ipsen BioPharm Ltd Form 483, 2014-07-08

FDA issued a Form 483 to Ipsen BioPharm Ltd on 2014-07-08 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

Ipsen BioPharm Ltd · Wrexham, United Kingdom · Issued July 8, 2014

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Jul 2014
21 CFR 211.192

No written record of investigation

Cited by Uttaniti Limchumroon

Inspected site

IBIpsen BioPharm LtdWrexham, United Kingdom

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere